ABELIAN THERAPEUTICS
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease.
ABELIAN THERAPEUTICS
Industry:
Biotechnology Health Diagnostics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
617 338-2072
Total Funding:
0
Investors List
F-Prime Capital
F-Prime Capital investment in Seed Round - Abelian Therapeutics
More informations about "Abelian Therapeutics"
Abelian Therapeutics - Funding, Financials, Valuation & Investors
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Abelian Therapeutics - Products, Competitors, Financials, …
About Abelian Therapeutics. Abelian Therapeutics is a biotechnology company. It develops a solution focusing on the role of Glia cells in addressing various brain diseases. It was founded …See details»
Abelian Therapeutics - Crunchbase
Abelian Therapeutics focuses on factors in brain disease, while Liquid Biotech and Siva Therapeutics are involved in cancer diagnostics and treatment using technology and …See details»
ABELIAN THERAPEUTICS, INC. :: Massachusetts (US)
Free and open company data on Massachusetts (US) company ABELIAN THERAPEUTICS, INC. (company number 001307141), 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA, 02472. …See details»
Abelian Therapeutics - VentureRadar
858 Therapeutics USA Privately Held 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in …See details»
ABELIAN THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates
Free and open company data on Delaware (US) company ABELIAN THERAPEUTICS, INC. (company number 6675379)See details»
Abelian Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Last update 23 Jan 2025. Abelian Therapeutics, Inc. Startups |See details»
ABELIAN THERAPEUTICS, INC. in Boston, MA - Bizapedia
Jul 20, 2024 ABELIAN THERAPEUTICS, INC. is a Massachusetts Foreign Corporation filed on January 9, 2018. The company's File Number is listed as 001307141. The Registered Agent …See details»
ABELIAN THERAPEUTICS, INC. in Dover, DE - Bizapedia
Dec 20, 2024 ABELIAN THERAPEUTICS, INC. is a Delaware Corporation filed on December 22, 2017. The company's File Number is listed as 6675379 . The Registered Agent on file for …See details»
Neumora launches with $500 million to develop drugs …
Oct 7, 2021 Neumora has also acquired the early-stage startup Abelian Therapeutics, which was studying the role of glial cells in brain disease. Williams says Neumora has also been developing its own ...See details»
About | The Abelian Group
Abelian Solutions. We become your partners as you navigate the AI landscape, helping you identify the tools and strategies that fit your business goals—whether that means adopting …See details»
Brain Wave: Neumora Aims Precision Medicine at Neuro Diseases …
Nov 2, 2021 Boston-based Abelian Therapeutics, a drug developer focused on harnessing and investigating glial cells as factors in brain disease; Alairion (Cambridge MA), a startup focused …See details»
Abelian Therapeutics, Inc. (Abelian Therapeutics, Inc.) - 药物管线_ …
了解Abelian Therapeutics, Inc. (Abelian Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的2篇新闻。See details»
Abelian Therapeutics - Updates, News, Events, Signals & Triggers
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease.See details»
3年B轮IPO，这家药企把资本玩明白了 - 投资界
Sep 20, 2023 3年b轮ipo，这家药企把资本玩明白了,3年多时间，总融资额超6亿美元，曾一年内收购5家公司，与安进达成合作，7款在研药物，1款进入临床Ⅲ期 ...See details»
Similar companies to Abelian Therapeutics | VentureRadar
Inception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. Inception’s …See details»
Armed with half a billion dollars, a startup aims to change how …
Oct 7, 2021 BlackThorn has since become a building block for Neumora, which acquired the the company along with private biotechs Abelian Therapeutics and Alairion and a machine …See details»
2025年，BioTech的首个股价暴跌出现！跌幅超过80% - 知乎
因资金足够到位，Neumora在成立后接连收购了5家专注神经科学领域的小公司，分别为Abelian Therapeutics、BlackThorn Therapeutics、Syllable Life Sciences、Propellex Bio和Alairion。 …See details»
曾1年内收购5家公司，脑疾病药物开发公司闯关IPO，核心产品已 …
Aug 29, 2023 同年，Neumora 收购了另外 4 家公司，最终获得数十个候选产品：Abelian Therapeutics 是一家药物开发商，专注于利用和研究神经胶质细胞作为脑部疾病的因 …See details»
Beam Therapeutics Announces Positive Initial Data for BEAM-302 …
CAMBRIDGE, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base …See details»